Cryptosporidiosis
Recent clinical, regulatory, research and industry developments relating to this disease.
Waterborne transmission of protozoan parasites: a worldwide review of outbreaks and lessons learnt.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
- 1 clinical trial expected to report results, the earliest in Q1 2027.
Clinical MilestonesViewHide
Clinical trials
The current development programme across all trial phases.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Major themes6
- Cryptosporidiosis1
- Cryptosporidium1
- Disease Outbreaks1
- Giardiasis1
- Global Health1
- Parasites1
Leading journals1
- Journal of water and health2
Leading researchers6
- Karanis P2
- Bourli P1
- Eslahi AV1
- Kourenti C1
- Smith H1
- Tzoraki O1
Affiliations (unnormalised)4
- Medical Faculty and University Hospital1
- Medical Microbiology Research Center1
- National Research Center for Protozoan Diseases1
- School of the Environment1
Associated genes
Genes associated with this disease in the canonical knowledge graph (Open Targets evidence). Number shows the association score.
Reference
Authoritative identity, definition & identifiers.
Intestinal infection with organisms of the genus CRYPTOSPORIDIUM. It occurs in both animals and humans. Symptoms include severe DIARRHEA.
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.